• Return to Headlines

Biocryst Pharm Shares Up 5.2% Since SmarTrend's Buy Recommendation (BCRX)

By David Diaz

SmarTrend identified an Uptrend for Biocryst Pharm (NASDAQ:BCRX) on January 4th, 2019 at $8.49. In approximately 3 weeks, Biocryst Pharm has returned 5.18% as of today's recent price of $8.93.

Over the past year, Biocryst Pharm has traded in a range of $4.25 to $9.75 and is now at $8.93, 110% above that low. The 200-day and 50-day moving averages have moved 1.29% higher and 1.12% higher over the past week, respectively.

BioCryst Pharmaceuticals, Inc. designs, optimizes, and develops small-molecule novel pharmaceuticals that block key enzymes involved in infectious diseases, inflammatory diseases, and cancer. The Company has late-stage compounds in development and continues to discover additional compounds and to progress them to meet the unmet medical needs of patients and physicians.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Biocryst Pharm shares.

Log in and add Biocryst Pharm (BCRX) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights biocryst pharm

Ticker(s): BCRX